Search research articles
Contact Us
Filters
Showing results (841-850 of 1,050) with videos related to
Page
of 105
Sort By:
Brain : a Journal of Neurology
|
August 1, 1991
New observations on the normal auditory startle reflex in man
P Brown, J C Rothwell, P D Thompson, et al.
Journal of Neural Transmission
|
January 1, 1985
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs
N M Rupniak, M D Hall, E Kelly, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1991
Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep
D R Fish, D Sawyers, S J Smith, et al.
Psychopharmacology
|
January 1, 1992
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
K W Lange, T W Robbins, C D Marsden, et al.
Lancet (London, England)
|
June 5, 1982
Tardive dystonia and inappropriate use of neuroleptic drugs
R E Burke, S Fahn, J Jankovic, et al.
Neuropharmacology
|
August 1, 1986
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area
A J Bradbury, B Costall, P G Jenner, et al.
Neuropharmacology
|
October 1, 1989
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin
A Ueki, P N Chong, A Albanese, et al.
Neuroscience Letters
|
April 10, 1987
Modulation of the long-latency reflex to stretch by the supplementary motor area in humans
J P Dick, J C Rothwell, B L Day, et al.
Biochemical Pharmacology
|
August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat
N M Rupniak, M D Hall, S Mann, et al.
European Journal of Pharmacology
|
January 12, 1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets
S Rose, M Nomoto, E A Jackson, et al.
Page
of 105
Search research articles
Search
Showing results (841-850 of 1,050) with videos related to
Sort By:
Page
of 105
Brain : a Journal of Neurology
|
August 1, 1991
New observations on the normal auditory startle reflex in man
P Brown, J C Rothwell, P D Thompson, et al.
Journal of Neural Transmission
|
January 1, 1985
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs
N M Rupniak, M D Hall, E Kelly, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1991
Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep
D R Fish, D Sawyers, S J Smith, et al.
Psychopharmacology
|
January 1, 1992
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
K W Lange, T W Robbins, C D Marsden, et al.
Lancet (London, England)
|
June 5, 1982
Tardive dystonia and inappropriate use of neuroleptic drugs
R E Burke, S Fahn, J Jankovic, et al.
Neuropharmacology
|
August 1, 1986
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area
A J Bradbury, B Costall, P G Jenner, et al.
Neuropharmacology
|
October 1, 1989
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin
A Ueki, P N Chong, A Albanese, et al.
Neuroscience Letters
|
April 10, 1987
Modulation of the long-latency reflex to stretch by the supplementary motor area in humans
J P Dick, J C Rothwell, B L Day, et al.
Biochemical Pharmacology
|
August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat
N M Rupniak, M D Hall, S Mann, et al.
European Journal of Pharmacology
|
January 12, 1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets
S Rose, M Nomoto, E A Jackson, et al.
Page
of 105